Literature DB >> 11102495

Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells.

J S Yeomans1, J Takeuchi, M Baptista, D D Flynn, K Lepik, J Nobrega, J Fulton, M R Ralph.   

Abstract

Oligonucleotides targeting M5 muscarinic receptor mRNA were infused for 6 d into the ventral tegmental area of freely behaving rats trained to bar-press for lateral hypothalamic stimulation. The bar-pressing rate was determined at a range of frequencies each day to evaluate the effects of infusions on reward. M5 antisense oligonucleotide (oligo) infusions increased the frequency required for bar pressing by 48% over baseline levels, with the largest increases occurring after 4-6 d of infusion. Two control oligos had only slight effects (means of 5 and 11% for missense and sense oligos, respectively). After the infusion, the required frequency shifted back to baseline levels gradually over 1-5 d. Antisense oligo infusions decreased M5 receptors on the ipsilateral, but not the contralateral, side of the ventral tegmentum, as compared with a missense oligo. Therefore, M5 muscarinic receptors associated with mesolimbic dopamine neurons seem to be important in brain-stimulation reward.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102495      PMCID: PMC6773088     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Behavioral measures of conduction velocity and refractory period for reward-relevant axons in the anterior LH and VTA.

Authors:  B Murray; P Shizgal
Journal:  Physiol Behav       Date:  1996 Apr-May

2.  Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.

Authors:  P B Clarke; A Pert
Journal:  Brain Res       Date:  1985-12-02       Impact factor: 3.252

3.  Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats.

Authors:  J U Adams; X Chen; J K DeRiel; M W Adler; L Y Liu-Chen
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

4.  Pimozide and amphetamine have opposing effects on the reward summation function.

Authors:  C R Gallistel; D Karras
Journal:  Pharmacol Biochem Behav       Date:  1984-01       Impact factor: 3.533

5.  Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; A C Young; M R Brann; N J Buckley
Journal:  Neuron       Date:  1988-07       Impact factor: 17.173

6.  Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat.

Authors:  S Ogawa; U E Olazábal; I S Parhar; D W Pfaff
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

7.  Sequence-specific impairment of learning by c-jun antisense oligonucleotides.

Authors:  W Tischmeyer; R Grimm; H Schicknick; W Brysch; K H Schlingensiepen
Journal:  Neuroreport       Date:  1994-07-21       Impact factor: 1.837

Review 8.  Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia.

Authors:  J S Yeomans
Journal:  Neuropsychopharmacology       Date:  1995-02       Impact factor: 7.853

9.  Cholinergic involvement in lateral hypothalamic rewarding brain stimulation.

Authors:  J S Yeomans; O Kofman; V McFarlane
Journal:  Brain Res       Date:  1985-03-11       Impact factor: 3.252

10.  Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.

Authors:  M Nisell; G G Nomikos; T H Svensson
Journal:  Synapse       Date:  1994-01       Impact factor: 2.562

View more
  20 in total

Review 1.  Forebrain substrates of reward and motivation.

Authors:  Roy A Wise
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

Review 2.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

Review 3.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

4.  Age-related changes in nicotine response of cholinergic and non-cholinergic laterodorsal tegmental neurons: implications for the heightened adolescent susceptibility to nicotine addiction.

Authors:  Mark H Christensen; Masaru Ishibashi; Michael L Nielsen; Christopher S Leonard; Kristi A Kohlmeier
Journal:  Neuropharmacology       Date:  2014-05-24       Impact factor: 5.250

5.  Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice.

Authors:  Morgane Thomsen; Craig W Lindsley; P Jeffrey Conn; Jeffrey E Wessell; Brian S Fulton; Jürgen Wess; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2011-10-01       Impact factor: 4.530

6.  Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues.

Authors:  W Zhou; H Liu; F Zhang; S Tang; H Zhu; M Lai; P W Kalivas
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

7.  Separating analgesia from reward within the ventral tegmental area.

Authors:  E Schifirneţ; S E Bowen; G S Borszcz
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

8.  Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.

Authors:  Guangrong Zheng; Andrew M Smith; Xiaoqin Huang; Karunai L Subramanian; Kiran B Siripurapu; Agripina Deaciuc; Chang-Guo Zhan; Linda P Dwoskin
Journal:  J Med Chem       Date:  2013-02-18       Impact factor: 7.446

9.  Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area.

Authors:  Steven R Laviolette; Tania O Alexson; Derek van der Kooy
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

10.  Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission.

Authors:  Miguel Garzón; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2013-09-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.